Buy out?, page-40

Some of what you say does makes a little sense, but I don't think your conclusions are necessarily "reasonable". It seems like there's a lot of contradictions!

For example you state early on:

"For the record, I don't think Amgen wants to take a strategic stake in UNS and they definitely don't want to buy it."

Yet your final conclusion for Amgen's perspective is that:

"The solution for Amgen is a strategic stake in UNS. It is easy for them, they just have to monitor the company and crack a few heads when UNS steps out of line."

So in your opinion do they want a stake or don't they?????

Further on, you say that UNS don't want this a stake by Amgen in UNS will kill all growth opportunities. Can you explain why and how?

Afaik the % of UNS that Amgen are looking to aquire is 19.9%, which does not get them a board seat? So while Amgen will want their interests looked after, ultimately they won't be making any decisions for unilife? I don't deny that a partnership with Amgen may make deals with other pharma's potentially more difficult, but to say kill all growth opportunites is surely a hyperbole? And what about growth opportunities with Amgen products?!